Table 3.
Pathological response rates
| Major pathological response | Pathological complete response | |
|---|---|---|
| Intention-to-treat population | 16/31(51.6%) | 7/31(22.6%) |
| Cancer type* | ||
| Adenocarcinoma | 6(37.5%) | 2(28.6%) |
| Squamous cell carcinoma | 10(62.5%) | 5(71.4%) |
| P value | 0.317 | 0.257 |
| Preoperative nodal stage | ||
| N1 | 12(75%) | 4(57.1%) |
| N2 | 4(25%) | 3(42.9%) |
| P value | 0.046 | 0.705 |
| Stage at presentation | ||
| IIA or IIB | 12(75%) | 4(57.1%) |
| IIIA | 4(25%) | 3(42.9%) |
| P value | 0.046 | 0.705 |
Data are n/N (%) unless otherwise indicated.
Only includes patients who underwent successful R0 surgical resection.